Puration, Inc. (PURA)

Get Top Rated Stock Alerts Active Traders Depend On

Sign Up Today For FREE News Driven Alerts

Puration Brings EVERx CBD Sports Water To Africa At Arnold Sports Festival Johannesburg As Tana Body Painting Revolution Sponsor

Dallas, TX – April 30, 2019 – Puration, Inc. (USOTC: PURA) today announced its EVERx CBD Sports Water will debut in Africa at the Arnold Sports Festival in Johannesburg, South Africa May 17-19.  EVERx was officially launched for the first time ever at the Arnold Classic in Columbus, Ohio in 2017, and now EVERx expands its presence at the Arnold Sports Festival  events worldwide.  EVERx today is the leading CBD infused sports nutrition beverage with over $1 million in sales. EVERx is now an official sponsor of Jan Tana’s Body Painting Revolution featured globally at Arnold Sports Festival venues worldwide and the EVERx booth can be found near Jan Tana’s Body Painting Revolution Stage in Johannesburg.

 

 

Jan Tana’s Bodypainting Revolution, A colorful and artistic event, returns to The Arnold in South Africa for the second straight year in 2019 after a spectacular recent production at the Arnold Classic Sports Festival in Columbus, Ohio.  This unique art exhibition and competition will take place completely in public view as artists paint models, taking more than six hours to complete in hopes to impress the judges, captivate photographers and delight audiences with breathtaking stage performances.

 

 

The Arnold Sport Festival hosts multi-sport festivals on six-continents each year, including the Arnold Classic Africa, which takes place in Johannesburg, Gauteng, each May. The Arnold Sports Festival USA is held in Columbus, Ohio in March, followed by events in Melbourne, Australia, Brazil, Hong Kong and Spain. All events feature professional bodybuilding and related contests, amateur bodybuilding, strength and combat sports, a large health and fitness expo and youth events that vary from continent to continent.

 

 

“The Arnold Classic Worldwide brand is now the largest series of multi-sport festivals in the world and we look forward to making each of our Arnold Classic weekends better than our previous best,” said James J. Lorimer, CEO of Classic Productions, Inc., who co-founded the Arnold Classic in Columbus with Governor Schwarzenegger.

 

Three years ago, four South African bodybuilding and sports enthusiasts collaborated to make the Arnold Sports Festival a reality on the African continent under the broad theme ‘My Sport, My Passion’. In partnership with the Gauteng Provincial Government and the SA Sports Confederation and Olympic Committee (SASCOC), Arnold Classic Africa affords athletes the opportunity to compete in an international competition, against participants from all continents, in Africa. Like its global counterparts, the African rendition embraces numerous sporting codes and promotes these through demonstrations, contests, record attempts and sports celebrities over three days each May.

 

Arnold Sport Festival Africa 2019 will take place over 4 venues, Sandton Convention Centre is the main venue, where the Trade Expo will also take place, Crawford College will host some of our various sporting codes, Country Club Johannesburg will be the venue for our Golf Classic, and Ten Pin Bowling will take place at the Northcliff Bowl.

 

For more information on Puration, visit http://www.purationinc.com

 

For more information on Jan Tana, visit https://www.jantana.com/

 

Disclaimer/Safe Harbor:

 

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

 

Contact:

Puration, Inc.

Brian Shibley,

info@aciconglomerated.com

(800) 861-1350

 

Source:  Puration, Inc.

 

Puration Speculative Buy Confirmed With $0.25 Target PPS And $0.35 PPS Potential Upside In Updated Analyst Report

Dallas, TX – February 28, 2019 – Puration, Inc. (USOTC: PURA) today announced that Goldman Small Cap Research issued a research update on the Company. The report includes a ‘speculative-buy’ rating with a target price-per-share of $0.25, with noted potential upside to the $0.35 mark. The  update reviews recent events and provides an analysis of Puration’s recent new initiatives. To view the update report, along with disclosures and disclaimers, visit http://www.GoldmanResearch.com.

 

Puration Goldman Small Cap Research Update Highlights

 

Puration, Inc. is a leading Texas-based, CBD-infused beverage provider. The Company’s flagship product, EVERx, which was introduced in 2017, targets the sports nutrition market. Puration plans to introduce new beverages as well as grow it product portfolio organically as well as through targeted acquisitions. As of October 2018, the Company was set to spin off its cannabis cultivation segment to focus its efforts exclusively on its high-growth core CBD-infused beverage business.

 

According to  a report by the Brightfield Group, the hemp-derived CBD market is forecast to reach $22 billion in 2022. Given that the market remains fragmented, fast-growing PURA is well positioned to capture market share very quickly.

 

In the Opportunity Research update, analyst Rob Goldman discusses the Company’s strong initiatives, and exciting upcoming opportunities that lie ahead.

 

Goldman noted, “In a business segment that features pretenders and also-rans, PURA is already a clear winner and emerging leader. Since our November 2018 update, PURA has signed a major contract, introduced new formulations/packaging, added global distribution and is enjoying substantial repeat orders. As a result, our FY19 $3M in revenue estimate could be low. Given the M&A, investment and business exploration activity by major consumer products companies, we expect PURA to return to its 52-week high of $0.25 with potential upside to the $0.35 mark and be considered an M&A candidate.”

 

“PURA has bagged a $1.5M custom CBD extracts order with Generex Biotechnology, gone global with a new European distributor and is a major sponsor of key events such as the 2019 The Arnold Sports Festival, which will be attended by 200,000 visitors watching 22,000 athletes compete.”

 

“There is substantial interest in hemp-derived CBD-infused products, as evidenced by the flurry of M&A, investment activity and talk by major beverage companies such as Constellation, Brands, Diageo, Tilray, Coca-Cola, Starbucks, etc.  Once critical mass of sales is achieved, given its broad popularity, PURA could emerge as an M&A target,” concluded Goldman.

 

About Goldman Small Cap Research: Founded in 2009 by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and microcap stock research reports, articles, stock market blogs, and popular investment newsletters.

 

Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co.

 

This press release contains excerpts of our most recently published sponsored company research report on Puration, Inc. which carries a rating and a price target.  The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research relied solely upon information derived from Puration, Inc. (“the Company”) authorized press releases or legal disclosures made in its filings with the U.S. Securities and Exchange Commission http://www.sec.gov.

 

Separate from the factual content of our report about the Company, we may from time to time include our own opinions about the Company, its business, markets and opportunities. Any opinions we may offer about the Company are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice. Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results.

 

A Goldman Small Cap Research report, update, newsletter, article, trading alert, corporate profile, or press release is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed is to be used for informational purposes only.  Please read all associated full disclosures, disclaimers, and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other regulatory agency. To download this research report or any of our research, view our disclosures and disclaimers, or for more information, visit www.goldmanresearch.com. Since 2018, Goldman Small Cap Research has been compensated $7000 by the Company for research and distribution services. GSCR was not compensated for the production and distribution of this update.

 

About Puration, Inc.  (OTC – PURA) Puration, Inc. is a leading Texas-based, CBD-infused beverage provider. The Company’s flagship product, EVERx, which was introduced in 2017, targets the sports nutrition market. Puration plans to introduce new beverages as well as grow it product portfolio organically as well as through targeted acquisitions. As of October 2018, the Company was set to spin off its cannabis cultivation segment to focus its efforts exclusively on its high-growth core CBD-infused beverage business.

 

For more information, please visit: www.PurationInc.com

 

Goldman Small Cap Research

Rob Goldman, Analyst

410-609-7100

rob@goldmanresearch.com

 

Source:  Puration, Inc.

Puration, Inc. Debuts All New EVERx CBD Sports Water At 2019 Arnold Sports Festival As Jan Tana’s Body Painting Revolution Sponsor

Dallas, TX – February 27, 2019 – Puration, Inc. (OTCPK: PURA) today announced its EVERx CBD Sports Water is returning to the Arnold Sports Festival for a third consecutive year.  EVERx was officially launched for the first time ever at the Arnold in 2017, and this year EVERx returns to the Arnold with its all new EVERx formula and packaging right in the center of the Expo as a major event sponsor.  The EVERx booth can be found near Jan Tana’s Body Painting Revolution stage.  EVERx is a sponsor of Jan Tana’s Body Painting Revolution.

 

 

Jan Tana’s Bodypainting Revolution, A colorful and artistic event, returns to The Arnold Classic Sports Festival for the second straight year in 2019.  This unique art exhibition and competition will take place in public view in the Expo Hall Booth #1307.  Artists will paint models, taking more than six hours to complete in hopes to impress the judges, captivate photographers and delight audiences with breathtaking stage performances.  Bodypainting artists will take you back to your favorite Arnold Movie with this year’s inspiring theme “Classic Arnold Cinema.”

 

 

The 2019 Arnold Sports Festival and the world-renowned Arnold Classic bodybuilding championships, already the world’s largest multi-sport festival, will grow even larger in 2019 when the four-day health and fitness celebration presents a record 80 sports and events February 28-March 3, 2019 in Columbus, Ohio.

 

 

The Arnold Sports Festival will attract an estimated 200,000 sports and fitness fans to watch more than 22,000 athletes compete in 80 sports and events, including 16 Olympic events, at the Greater Columbus Convention Center in downtown Columbus, the Ohio Expo Center and various other Central Ohio venues.

 

The Arnold Classic and related IFBB Pro League events and the Arnold Amateur NPC Bodybuilding, Fitness, Figure, Bikini & Physique Championships will be held in Battelle Grand and on the Arnold Fitness EXPO Stage at the Greater Columbus Convention Center.

 

An expanded Arnold SportsWorld Kids & Teens EXPO will be held March 2-3 at the Ohio Expo Center. Archery, Baton Twirling, Cheerleading, Futsal, Gymnastics, Martial Arts, Pickleball, Table Tennis and XPC Powerlifting/POWER X are among the events at the Ohio Expo Center.

 

The Arnold Fitness EXPO, March 1-3, 2019 at the Greater Columbus Convention Center, features more than 1,000 booths of the latest in sports equipment, apparel and nutrition and four stages that host competitions and entertainment.

 

For more information on Puration, visit http://www.purationinc.com

 

For more information on Jan Tana, visit https://www.jantana.com/

 

Disclaimer/Safe Harbor:

 

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

 

Contact:

Puration, Inc.

Brian Shibley,

info@aciconglomerated.com

(800) 861-1350

 

Source: Puration, Inc.

 

Puration Plans Major Cannabis Beverage Announcement To Coincide With Starbucks And Tilray Heating Up Cannabis Beverage Sector

Dallas, TX – February 26, 2019 – Puration, Inc. (USOTC: PURA) today previewed a major coming announcement regarding its EVERx CBD Sports Water planned for release later this week. The announcement coincides with the cannabis beverage industry beginning to heat up again after Tilray) announced the acquisition of Manitoba and “eyeing the growing CBD food and drink market in the U.S.”   News is also just out that Starbucks) could be the first big chain to launch a cannabis drink.  “While some big players are now starting to get interested in producing a CBD infused drink, PURA has just launched a second generation formulation of its EVERx CBD Infused Water,” said Brian Shibley, CEO of PURA. “We are about to celebrate the anniversary of the EVERx launch in 2017 in a big way.  Stay tuned for announcement later this week.”

 

For more information on Puration, visit http://www.purationinc.com

 

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Contact: Puration, Inc.
Brian Shibley,
info@aciconglomerated.com

 

Source: Puration Inc.

Kali-Extracts Inc Announces $300,000 Contract to Produce Hemp-Derived CBD Extract for Puration Inc

Dallas, TX – December 10, 2018 – Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) today announced a $300,000 contract with Puration, Inc. (USOTC: PURA) (“PURA”) to produce custom hemp-derived CBD extracts.  Kali-Extracts recently acquired a patented cannabis extraction process, that comes with a substantial volume of associated clinical research, in a reverse merger transaction with NCM Biotech.  Kali-Extracts is accordingly in the process of rapidly updating the company’s public filings with OTCMarkets to both post the legacy operations past-due filings and to reflect the current cannabis extraction business.  Kali-Extracts has a new website (www.kali-exracts.com) that includes a presentation of the company’s new cannabis extraction business plan. Now, less than one month after the reverse merger transaction, where Kali-Extracts acquired the patented cannabis extraction process, the company has signed its first revenue producing contract.

 

“With the legalization of hemp farming on the near horizon as drafted into the pending 2018 Farm Act, the flood gates are about to open for Kali-Extracts,” Said Frederick Ferri, the founder of NCM Biotech, and the incoming CEO of Kali-Extracts. “I am already receiving daily inquiries to formulate custom hemp-derived CBD extractions.  The pending legalization of hemp farming, combined with the recent DEA removal of CBD from schedule 1, is igniting the commercialization of hemp-derived CBD concentrates for a multitude of applications from pharmaceutical to sports nutrition to over the counter pain management to general health and wellness.”

 

Kali-Extracts Partnership with Puration, Inc.

 

Kali-Extracts and Puraiton, Inc. have a long-term partnership that predates the reverse merger of NCM Biotech into Kali-Extracts.  Puration has the sole license of the Kali-Extracts patented cannabis extraction process – U.S. Patent No. 9,199,960 entitled “METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.”  In conjunction with Puration’s industry specific license, Puration currently produces EVERx CBD Sports Water, the leading CBD infused water in the sports nutrition market. Puration has trailing twelve-month revenues of approximately $1 million.  More recently, Kali-Extracts and Puration, with two other partners, have together formed a joint venture company (JV) titled US Cannabis Health.  The purpose of the JV is to pursue partnerships with pharmaceutical companies to produce cannabis extract pharmaceutical applications.  The JV has recently signed its first agreement, and in conjunction with that agreement, Puration will produce private labeled hemp-derived CBD infused water under the client pharmaceutical company’s name.  Puration has engaged Kali-Extracts to make a custom hemp-derived CBD extract specific to the requirements for the private labeled hemp-derived CBD water Puration will produce for the pharmaceutical company.

 

For more information visit:

 

www.kali-extracts.com

and

www.purationinc.com

 

Disclaimer/Safe Harbor:

 

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Puration, Inc.

 

Contact:

 

Puration, Inc.

Brian Shibley,

info@aciconglomerated.com

(800) 861-1350

 

Source:  Kali, Inc.

Puration Inc Reveals Recent Interest From Major Beverage Industry Brand Names

Dallas, Tx – October 16, 2018 – Puration, Inc. (OTCPK: PURA) today announced a podcast interview of Puration CEO Brian Shibley released by Goldman Small Cap Research. The interview provides an in-depth overview of where the CEO sees Puration in the cannabis infused beverage space as major beverage companies start to show interest and move into the market.  Hear the CEO discuss the recent interest in Puration’s EVERx CBD Sports Water shown by LA Libations, the key innovation partner of The Coca-Cola Company.  Coca-Cola owns a minority stake in LA Libations.  Also, here the CEO discuss Puration’s ongoing and developing relationship with Europa Sports Products, the leading distributor of nutritional sports supplements, sports drinks and accessories in the United States.

 

To listen to the interview, along with reading associated disclosures and disclaimers, visit http://www.goldmanresearch.com/201810151213/Opportunity-Research/puration-ceo-interview.html

 

Puration Interview Highlights

 

Puration, Inc. is a leading Texas-based, CBD-infused beverage provider. The Company’s flagship product, EVERx, which was introduced in 2017, targets the sports nutrition market. Puration plans to introduce new beverages as well as grow its product portfolio organically as well as through targeted acquisitions. As of October 2018, the Company spun off its cannabis cultivation segment to focus its efforts exclusively on its high-growth core CBD-infused beverage business.

 

According to Hemp Business Journal, the overall hemp-based CBD market is forecast to grow from $820 million in 2017 to $1.9 billion in 2022 and given that the market remains fragmented, fast-growing PURA is well positioned to capture market share very quickly.

 

During the interview, Puration CEO Brian Shibley and Goldman Small Cap Research founder Rob Goldman discussed recently demonstrated interest in the CBD infused beverage market by top tier beverage companies. These include Constellation Brands, Coca-Cola, Heineken, and others. Shibley also noted discussions Puration has recently engaged with an affiliate of Coca-Cola, LA Libations, along with a leading distributor in the sports nutrition market, Europa.

 

About Goldman Small Cap Research: Founded in 2009 by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and microcap stock research reports, articles, stock market blogs, and popular investment newsletters.

 

Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co.

 

This press release contains excerpts of our most recently published sponsored company research report on Alternet Systems, Inc. which carries a rating and a price target.  The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research relied solely upon information derived from Puration, Inc. (“the Company”) authorized press releases or legal disclosures made in its filings with the U.S. Securities and Exchange Commission http://www.sec.gov.

 

Separate from the factual content of our report about the Company, we may from time to time include our own opinions about the Company, its business, markets and opportunities. Any opinions we may offer about the Company are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice. Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results.

 

A Goldman Small Cap Research report, update, newsletter, article, trading alert, corporate profile, or press release is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed is to be used for informational purposes only.  Please read all associated full disclosures, disclaimers, and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other regulatory agency. To download this research report or any of our research, view our disclosures and disclaimers, or for more information, visit www.goldmanresearch.com. Goldman Small Cap Research was compensated $4500 by the Company for research and distribution services, including the production of this press release.

 

About Puration, Inc.  (OTC – PURA) Puration, Inc. is a leading Texas-based, CBD-infused beverage provider. The Company’s flagship product, EVERx, which was introduced in 2017, targets the sports nutrition market. Puration plans to introduce new beverages as well as grow it product portfolio organically as well as through targeted acquisitions. As of October 2018, the Company was set to spin off its cannabis cultivation segment to focus its efforts exclusively on its high-growth core CBD-infused beverage business.

 

For more information, please visit: www.PurationInc.com

 

Goldman Small Cap Research

Rob Goldman, Analyst

410-609-7100

rob@goldmanresearch.com

 

Source:  Puration, Inc.

Puration Inc Garners Interest From $330 Billion Beverage Industry Brand Name Players

DALLAS, Oct.11, 2018  — Puration, Inc. (USOTC: PURA) today released an online management presentation to provide more detail on its corporate restructuring to concentrate resources on its rapidly expanding cannabis infused beverage business.  The presentation includes details on the recently announced spinoff of its cannabis cultivation business and the pending dividend distribution of spinoff stock.  The presentation also includes details on the company’s current two cannabis infused beverages and the recently announced letter of intent to acquire a company with a third cannabis sector beverage. The presentation highlights the company’s overall strategy to optimize the movement of major brand name beverage industry players into the cannabis sector in addition to reporting recent interest shown by some brand name players into Puration’s experience in the cannabis infused beverage sector.  View the presentation on the company’s website or read the narrative from the presentation included in its entirety below:

 

Puration Cannabis Infused Beverage Industry Restructuring Strategy Presentation

 

Major beverage industry players are jockeying for position in the nascent cannabis infused beverage market. Canada’s legalization of recreational marijuana, which goes into effect next week, triggered Fortune 500 sized interest in the cannabis sector. Up until Canada’s vote to legalize recreational marijuana, large corporations and investment houses remained on the sidelines. Now Corona Beer parent Constellation Brands has jumped in to the cannabis sector making a $4 billion investment. Coca-Cola is “eyeing” the CBD sector and Molson Coors Brewing Co. has announced a partnership to develop a non-alcoholic cannabis infused beverage for the Canadian market.  Soft drink sales in the U.S. total $112 billion annually and alcohol beverage sales in the U.S. total $223 billion.

 

With such household brand names in an industry producing over $330 billion in sales annually now taking interest in cannabis infused beverages, Puration finds itself in an enviable position having not only already developed and produced a cannabis infused beverage, but also having earned over a year’s worth of hard knocks experience marketing and distributing its cannabis infused beverages.  Puration’s cannabis infused beverages are on shelves in sports nutrition retailers, liquor stores and dispensaries.  The company’s experience has of late attracted the attention of some beverage industry heavyweights and with reaching the $1 million in annual sales benchmark now on a not too distant horizon, that interest could potentially grow into a more committed relationship. Look for an upcoming interview of Puration CEO Brian Shibley to be published next week to learn more about the recent interest in Puration’s cannabis infused beverage experience.

 

Puration’s 600% Cannabis Infused Beverage Sales Growth Experience

 

Puration debuted its EVERx CBD Sports Water early last year at Arnold Schwarzenegger’s Arnold Sports Festival. EVERx has since become the leading CBD infused beverage in the sports nutrition marketplace. The company reported 600% sales growth in the second quarter of this year and recently announced a $1 million annual revenue benchmark being potentially within reach for 2018.  The company has its first THC infused beverage, THCSavor, under development and has recently announced a letter of intent to acquire a company with a third cannabis sector beverage.  The acquisition is anticipated to be completed later this month.

 

Puration’s History From Cannabis Extraction Patent To Beverage Producer

 

Puration entered the cannabis sector when it acquired the rights to a patented cannabis extraction process from North American Cannabis Holdings, Inc. (USMJ). The entrepreneurial business plan has evolved since the acquisition with the company now concentrating its cannabis sector expertise and experience exclusively on the production of cannabis infused beverages. Today, the company maintains its patented cannabis extraction license as part of its strategy to produce differentiated cannabis infused beverages.

 

Puration’s Cannabis Cultivation Spinoff

 

To streamline and concentrate all its resources on the production of cannabis infused beverages, Puration has recently spun-off its cannabis cultivation operation.  The spinoff was affected through the execution of a securities exchange agreement with Nouveau Life Pharmaceuticals, Inc., (NOUV) (“NOUV”).  Puration sold its cannabis cultivation business in exchange for a convertible purchase note issued by NOUV.  Puration and NOUV have agreed to a recapitalization plan for NOUV and a post recapitalization conversion of the purchase note into a number of common NOUV shares sufficient to issue one NOUV common share for every five shares of Puration common shares issued and outstanding.  All of the NOUV common shares issued in conversion of the purchase note are slated for distributed to Puration shareholders in a dividend distribution.  Look for a presentation coming soon from NOUV on its business plans for the cannabis cultivation business.

 

Puration’s Pending Stock Dividend Distribution

 

Now that the securities exchange agreement between NOUV and Puration is finalized, NOUV is working to rapidly come current with its financial reports. Once NOUV is current, the company will initiate a recapitalization. Following the recapitalization, the purchase note will be converted into NOUV common shares and Puration will initiate the necessary steps to issue the converted NOUV shares to Puration shareholders through a dividend distribution. The first steps leading to the stock dividend distribution are underway, and the combined management teams are committed to a prompt delivery of the planed stock dividend.

 

Goldman Small Cap Puration Research Report: Speculative-Buy and Target $0.25 PPS

 

Goldman Small Cap Research issued a research report on Puration, Inc. published October 10, 2018. The report includes a ‘speculative-buy’ rating with a target price-per-share of $0.25. The report provides an in-depth overview and analysis of Puration’s successes, approach, new initiatives, and upcoming milestones. To view the report, along with disclosures and disclaimers, visit http://www.GoldmanResearch.com or https://www.purationinc.com/goldman-research/.

 

Learn more about Puration at www.purationinc.com

 

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

 

Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
+(800)-861-1350

 

SOURCE Puration, Inc.

Puration Inc Sets Sights On 2018 Revenue Benchmark To Carve Out Leadership Stake In $1 Billion Cannabis Beverage Market Segment

DALLAS, Oct. 09, 2018 – Puration, Inc. (USOTC: PURA) (“PURA”) today announced setting its sights on breaking through the $1 million revenue benchmark in 2018.  PURA is a rapidly growing cannabis beverage producer and management believes sales could exceed $1 million this year, 2018.  The company introduced EVERx CBD Sports Water last year, and it has become the leading cannabis beverage brand name in the sports nutrition marketplace.  Distribution is growing rapidly.  The company has just launched its first production run with its new labels to fill outstanding orders within new regions in the United States (and internationally).  The company’s first THC infused beverage, THCSavor, is in the works and is expected to launch soon.  The company also recently announced a pending acquisition to add yet a third cannabis beverage. According to a report by Brightfield Group, the hemp and CBD category alone is expected to be a $1 billion market by 2020 in the U.S.

 

EVERx CBD Sports Water has become the leading cannabis beverage brand name in the sports nutrition marketplace.

 

PURA announced last week the spinoff of its cannabis cultivation business.  The spinoff is part of the overall strategy for Puration to concentrate ongoing business development efforts on the company’s flourishing cannabis infused beverage business.  The spinoff announced last week has been effected through the execution of a securities exchange agreement with Nouveau Life Pharmaceuticals, Inc., (USOTC: NOUV) (“NOUV”).  PURA has sold its cannabis cultivation business in exchange for a convertible purchase note issued by NOUV.  All of the NOUV common shares issued in conversion of the purchase note are slated for distribution to PURA shareholders in a dividend distribution following a recapitalization of NOUV.

 

More details on the company’s rapidly expanding cannabis beverage business to include further details on the spinoff transaction will be included in an online presentation this Thursday, October 11th, 2018.

Learn more about Puration at www.purationinc.com

Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

 

Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350

 

Source: Puration Inc.

About Puration

PURATION, INC. (USOTC: PURA) Cannabis Beverage Brands

 

The producer of EVERx CBD Infused Sports Drink, the leading CBD beverage in the sports nutrition market place.

 

Cannabis-Beverage-Business-Plan

 

Puration Inc Garners Interest From $330 Billion Beverage Industry Brand Name Players

 

Puration, Inc. recently released an online management presentation to provide more detail on its corporate restructuring to concentrate resources on its rapidly expanding cannabis infused beverage business. The presentation includes details on the recently announced spinoff of its cannabis cultivation business and the pending dividend distribution of spinoff stock. The presentation also includes details on the company’s current two cannabis infused beverages and the recently announced letter of intent to acquire a company with a third cannabis sector beverage. The presentation highlights the company’s overall strategy to optimize the movement of major brand name beverage industry players into the cannabis sector in addition to reporting recent interest shown by some brand name players into Puration’s experience in the cannabis infused beverage sector. View the presentation on the company’s website or read the narrative from the presentation included in its entirety below:

 

Puration Cannabis Infused Beverage Industry Restructuring Strategy Presentation

 

Major beverage industry players are jockeying for position in the nascent cannabis infused beverage market. Canada’s legalization of recreational marijuana, which goes into effect next week, triggered Fortune 500 sized interest in the cannabis sector. Up until Canada’s vote to legalize recreational marijuana, large corporations and investment houses remained on the sidelines. Now Corona Beer parent Constellation Brands has jumped in to the cannabis sector making a $4 billion investment. Coca-Cola is “eyeing” the CBD sector and Molson Coors Brewing Co. has announced a partnership to develop a non-alcoholic cannabis infused beverage for the Canadian market.  Soft drink sales in the U.S. total $112 billion annually and alcohol beverage sales in the U.S. total $223 billion.

 

With such household brand names in an industry producing over $330 billion in sales annually now taking interest in cannabis infused beverages, Puration finds itself in an enviable position having not only already developed and produced a cannabis infused beverage, but also having earned over a year’s worth of hard knocks experience marketing and distributing its cannabis infused beverages. Puration’s cannabis infused beverages are on shelves in sports nutrition retailers, liquor stores and dispensaries. The company’s experience has of late attracted the attention of some beverage industry heavyweights and with reaching the $1 million in annual sales benchmark now on a not too distant horizon, that interest could potentially grow into a more committed relationship. Look for an upcoming interview of Puration CEO Brian Shibley to be published next week to learn more about the recent interest in Puration’s cannabis infused beverage experience.

 

Puration’s 600% Cannabis Infused Beverage Sales Growth Experience

 

Puration debuted its EVERx CBD Sports Water early last year at Arnold Schwarzenegger’s Arnold Sports Festival. EVERx has since become the leading CBD infused beverage in the sports nutrition marketplace. The company reported 600% sales growth in the second quarter of this year and recently announced a $1 million annual revenue benchmark being potentially within reach for 2018. The company has its first THC infused beverage, THCSavor, under development and has recently announced a letter of intent to acquire a company with a third cannabis sector beverage. The acquisition is anticipated to be completed later this month.

 

Puration’s History From Cannabis Extraction Patent To Beverage Producer

 

Puration entered the cannabis sector when it acquired the rights to a patented cannabis extraction process from North American Cannabis Holdings, Inc. (USMJ). The entrepreneurial business plan has evolved since the acquisition with the company now concentrating its cannabis sector expertise and experience exclusively on the production of cannabis infused beverages. Today, the company maintains its patented cannabis extraction license as part of its strategy to produce differentiated cannabis infused beverages.

 

Puration’s Cannabis Cultivation Spinoff

 

To streamline and concentrate all its resources on the production of cannabis infused beverages, Puration has recently spun-off its cannabis cultivation operation. The spinoff was affected through the execution of a securities exchange agreement with Nouveau Life Pharmaceuticals, Inc., (NOUV) (“NOUV”). Puration sold its cannabis cultivation business in exchange for a convertible purchase note issued by NOUV. Puration and NOUV have agreed to a recapitalization plan for NOUV and a post recapitalization conversion of the purchase note into a number of common NOUV shares sufficient to issue one NOUV common share for every five shares of Puration common shares issued and outstanding. All of the NOUV common shares issued in conversion of the purchase note are slated for distributed to Puration shareholders in a dividend distribution. Look for a presentation coming soon from NOUV on its business plans for the cannabis cultivation business.

 

Puration’s Pending Stock Dividend Distribution

 

Now that the securities exchange agreement between NOUV and Puration is finalized, NOUV is working to rapidly come current with its financial reports. Once NOUV is current, the company will initiate a recapitalization. Following the recapitalization, the purchase note will be converted into NOUV common shares and Puration will initiate the necessary steps to issue the converted NOUV shares to Puration shareholders through a dividend distribution. The first steps leading to the stock dividend distribution are underway, and the combined management teams are committed to a prompt delivery of the planed stock dividend.

 

EVERx CBD Infused Sports Drink

 

Puration launched the EVERx CBD Infused Sports Waters in the spring of 2017. EVERx has since become the leading CBD infused beverage in the sports nutrition market place. The company’s sales grew 600% in the first year after the launch of EVERx. Kiwi Strawberry and Lemon Lime flavors are now available in addition the Original EVERx CBD Infused Sports Water. EVERx has more than twice the CBD of most CBD infused waters on the market. A proprietary technology enables EVERx to suspend more CBD than its competitors and still have a crystal-clear appearance and a refreshing taste. The company has recently initiated a package redesign after extensive market testing of a new logo design. Consumer demand for CBD infused beverages is growing and Puration is likewise receiving inquiries from a broader array of retail outlets. The package redesign is the first step of a comprehensive marketing plan to dramatically increase EVERx sales over the next 24 months.

 

More Cannabis Beverages To Come

 

Building on Puration’s success with the introduction of it’s EVERx CBD Infused Sports Water, the company is reorganizing to concentrate its efforts on the cannabis beverage industry. The plan to concentrate on the cannabis beverage industry has been validated by global alcohol giant Constellation Brands’ (Corona Beer, among others) recent $4 billion investment in Canopy Growth. Puration has already launched an initiative to introduce a new THC infused beverage in Canada in conjunction with Canada’s nationwide legalization of recreational marijuana schedule to go into effect on October 17th. A formula for the beverage called THC Savor has already been developed and a distribution plan is already being built through Puration’s recent acquisition of a Canadian cannabis business earlier this year. Puration is implementing an acquisition campaign targeting other cannabis beverage operations as part of an overall strategy to accelerate an expansion of the company’s portfolio of cannabis beverage brands. The first cannabis beverage acquistion is well underway and could be completed before the end of 2018.

 

Extraction

 

Puration’s entrance into the cannabis sector was founded on a patented cannabis extraction process. The company’s original business plan was to establish a reputation for delivering the highest quality cannabis extract available. Management expected and still expects that consumer demand will grow for a variety of cannabis extracts to be infused in a variety of food and beverages. Puration’s original mission was to brand the company as the leading provider of cannabis extract such that consumers looked for the Puration name on their hemp oil salad dressing from Kraft, and their CBD infused beverage from Coca-Cola, and their THC infused cookies from Nabisco. While management still believes such products are coming, they recognize now Puration’s original mission was ahead of its time. Accordingly, the company adapted its plan and launched into making its own cannabis infused food and beverage products. The updated business plan is to focus on the cannabis infused beverage industry. However, before revising the business plan, while still working to build the highest quality extraction process in the market place, Puration had initiated a project to expand its extraction process upstream into cannabis cultivation. Having the best extracts depends not only on the extraction process itself, but also on the quality of the cannabis being extracted. Puration has cultivation operations in the United States and Canada. As part of the Puration’s current focus on cannabis beverages, the company plans to spin-off its cannabis cultivation business. The spin-off of the cannabis cultivation operation is not a discarding of excess weight, but rather a divide and conquer strategy. Standalone beverage and cultivation operations will be better situated to rapidly expand within their separate segments. In addition to maintaining all their current shares in Puration, shareholders will receive shares in the cultivation spinoff. The spin off plan includes a dividend distribution of stock in the cultivation business to the shareholders of Puration.

 

Management

 

Brian ShibleyCEO and Chairman

Brian Shibley is a well-known and successful real estate investor and developer. He originally became involved in Puration as a passive investor later taking over the Company’s senior management position to lead the Company through a transition into a new industry. Brian came to Puration as part of a broader investment strategy within the beverage industry. Puration was previously focused on reusable water bottles enable through a proprietary filter system. Brian was instrumental in two additional beverage industry launches – one in the distilled spirits industry and one in the health and wellness industry. After graduating from the University of Western Ontario, Canada, Brian moved to Providenciales, Turks and Caicos, where he designed and built homes, condominiums, hotels and casinos. After more than a decade in the Caribbean, Brian moved to Dallas Texas where he established his own real estate company in partnership with the renowned Tower Group to purchase land and correspondingly develop residential, commercial and hotel properties. For the last ten years, while continuing in the real estate business, Brian has also served as the CEO of a family owned underground utility company. Brian built the utility company into multimillion dollar operation that was recently sold in a private transaction. Brian has vast experience in building hotels and is often sought after by other developers to consult on complex hotel structures and developments. He has worked on projects throughout the Caribbean (most recently in Cuba), the Middle East and within the United States.

 

Steven RashDirector

Steven Rash is the CEO and Chairman of North American Cannabis Holdings in addition to being a partner in the firm holding a majority interest in North American Cannanbis Holdings. Mr. Rash is a medical industry veteran with a lengthy list of career accomplishments and experiences. He has negotiated medical device licensing agreements and health care partner strategic alliances that combined have generated over $650 million in new revenues. Mr. Rash has also managed numerous drug trials and secured multiple FDA approvals. He has signed over 400 managed care contracts and made more than 200 Boardroom presentations at Fortune 500 companies. Mr. Rash served as President and CEO of American BioMed, Vice President of Blue Rhino Corporation and Division President of Maxum Health Corporation. He earlier held numerous Vice President positions at BOC Group, PLC. Mr. Rash has a BS in Business Administration from the University of Delaware and an MBA from Southern Illinois University. Mr. Rash is also a Veteran of the United States Army.

 

Ed BollenDirector
Edward Bollen has served over 30 years with the U.S. government (USG) beginning with service in the U.S. Marine Corps. Following active duty, he worked with various military and law enforcement entities at the local, state and federal level (including the DEA). On behalf of the USG, he served as a “Contracting Officer Technical Representative ” (COTR) working with USG contractors to develop specialized equipment, projects or designs. Mr. Bollen worked in the U.S. intelligence community and the U.S. foreign service on the diplomatic front primarily in Africa and the Middle East.

 

Source:  https://www.purationinc.com/

Disclaimer

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG’s intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated forty nine hundred dollars for Puration, Inc. current news coverage by a non-affiliated third party.  FNMG HOLDS NO SHARES OF Puration, Inc.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Sign Up & Get FREE News Alerts From FNM Today!